Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
Ensem Therapeutics
Eli Lilly and Company
Novartis
Johns Hopkins University
National University Hospital, Singapore
AstraZeneca
Actuate Therapeutics Inc.
Novartis
Novartis
Haihe Biopharma Co., Ltd.
Institut de Cancérologie de Lorraine
UNICANCER
Duke University
Celcuity Inc
Novartis
Novartis
Novartis